Skip to main navigation
Skip to search
Skip to main content
Johns Hopkins University Home
Home
Profiles
Research units
Research output
Search by expertise, name or affiliation
Pharmacological therapy of lupus nephritis
Derek M. Fine
School of Medicine
Research output
:
Contribution to journal
›
Article
›
peer-review
27
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Pharmacological therapy of lupus nephritis'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Pharmacological Therapy
100%
Cyclophosphamide
100%
Lupus Nephritis
100%
Mycophenolate Mofetil
40%
Postpartum Period
20%
Older Women
20%
Systemic Lupus Erythematosus
20%
Malignancy
20%
Adverse Effects
20%
Increased Vulnerability
20%
World Health Organization
20%
Disease Control
20%
Infertility
20%
Hemorrhagic Cystitis
20%
Amenorrhea
20%
Susceptibility to Infection
20%
Bone Marrow Suppression
20%
Preserve Fertility
20%
Kidney Involvement
20%
Diffuse Proliferative Lupus Nephritis
20%
Women of childbearing Potential
20%
Medicine and Dentistry
Drug Therapy
100%
Lupus Nephritis
100%
Cyclophosphamide
83%
Disease
33%
Glucocorticoid
33%
Mycophenolic Acid
33%
Infection
16%
Puerperium
16%
Cancer
16%
Adverse Event
16%
Systemic Lupus Erythematosus
16%
Bone Marrow Suppression
16%
Hemorrhagic Cystitis
16%
Amenorrhea
16%
Pharmacology, Toxicology and Pharmaceutical Science
Pharmacotherapy
100%
Lupus Erythematosus Nephritis
100%
Cyclophosphamide
83%
Disease
33%
Glucocorticoid
33%
Mycophenolic Acid
33%
Adverse Event
16%
Infection
16%
Systemic Lupus Erythematosus
16%
Bone Marrow Suppression
16%
Amenorrhea
16%
Hemorrhagic Cystitis
16%